ELV vs UNH
Elevance Health and UnitedHealth Group, both Healthcare
UnitedHealth Group is the larger company at $364B against $84B. On trailing earnings ELV is the cheaper of the two at a P/E of 18.3 against 24.4, a gap that is only a bargain if the two are growing at similar rates. Over the past year ELV returned +33% against +16% for UNH. The RyuScore puts ELV ahead, 78 against 74 out of 100.
| Figure | ELV | UNH |
|---|---|---|
| Last close | $413 | $380 |
| Market cap | $84B | $364B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 18.3 | 24.4 |
| Dividend yield | n/a | 2.4% |
| 1-year return | +33% | +16% |
| 5-year return | +20% | -0.3% |
| RyuScoresector-relative, 1–10 | 78/100 | 74/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Elevance Health
Revenue of $50B in Q2 2026, net income $1.5B. Its largest reported line is Reportable, 89% of the disclosed total.
UnitedHealth Group
Revenue of $112B in Q2 2026, net income $5.5B. Its largest reported line is Total Optum, 50% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.